Last update April 28, 2026

Mestranol + Norethynodrel

Likely Compatibility

Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.

Combination contraceptive containing oestrogen (Mestranol) and progestogen (Noretinodrel) in the form of oral pills. It was the first contraceptive to be marketed (1959). Currently withdrawn from the market.

MESTRANOL: a synthetic estrogen that is metabolised to ethinylestradiol, which has similar actions to estradiol.

  • At the date of the last update, we found no published data on the excretion of mestranol in breast milk, but its metabolite, ethinylestradiol, is excreted in negligible or no amounts in breast milk.
  • There is evidence (although not consistent) that oestrogens may decrease milk production, especially during the first few weeks postpartum and at doses equal to or greater than 30 micrograms per day of ethinylestradiol. It may decrease the protein content of breast milk.
  • No problems have been observed in infants whose mothers took mestranol, except for one isolated case of transient gynaecomastia in an infant. (Curtis 1964)

NORETINODREL is a progestogen similar to norethindrone.

  • It is excreted in breast milk in clinically insignificant amounts (Laumas 1967, Pincus 1966) and no problems have been observed in infants whose mothers took it.

Breastfeeding rates are better when taking a progestogen-only hormonal contraceptive than when taking a combined oestrogen-progestogen contraceptive. (Goulding 2018) 

During breastfeeding, progestogen-only contraceptives are preferable to those combined with oestrogen and, in this case, those with lower oestrogen doses. (CDC 2016, WHO/OMS 2015, Altshuler 2015, Berens 2015, CLM 2012, Moretti 2000)

During the first 4-6 weeks postpartum, non-hormonal methods are the first choice, followed by IUDs and progestogen implants. (Berens 2015, Mwalwanda 2013, Rowe 2013, CLM 2012)


See below the information of these related products:

Alternatives

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Mestranol + Norethynodrel in other languages or writings:

Group

Mestranol + Norethynodrel belongs to this group or family:

Tradenames

Main tradenames from several countries containing Mestranol + Norethynodrel in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. - / 70 %
Molecular weight 310 / 298 daltons
Protein Binding - / 97 %
VD - / 4 l/Kg
Tmax - / 2 hours
- / 8 hours
M/P ratio - / 0.3 -
Theoretical Dose - / 0.0001 mg/Kg/d
Relative Dose - / 0.1 - 1 %

References

  1. (ABM) Johnson HM, Eglash A, Mitchell KB, Leeper K, Smillie CM, Moore-Ostby L, Manson N, Simon L; Academy of Breastfeeding Medicine.. ABM Clinical Protocol #32: Management of Hyperlactation. Breastfeed Med. 2020 Mar;15(3):129-134. Abstract Full text (link to original source)
  2. Espey E, Ogburn T, Leeman L, Singh R, Ostrom K, Schrader R. Effect of progestin compared with combined oral contraceptive pills on lactation: a randomized controlled trial. Obstet Gynecol. 2012 Abstract
  3. WHO / UNICEF. BREASTFEEDING AND MATERNAL MEDICATION Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs. Department of Child and Adolescent Health and Development (WHO/UNICEF) 2002 Abstract Full text (link to original source) Full text (in our servers)
  4. AAP - American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001 Sep;108(3):776-89. Abstract Full text (link to original source) Full text (in our servers)
  5. Dórea JG. Oral contraceptives do not affect magnesium in breast milk. Int J Gynaecol Obstet. 2000 Abstract
  6. Dorea JG, Myazaki E. Calcium and phosphorus in milk of Brazilian mothers using oral contraceptives. J Am Coll Nutr. 1998 Abstract
  7. Costa TH, Dorea JG. Concentration of fat, protein, lactose and energy in milk of mothers using hormonal contraceptives. Ann Trop Paediatr. 1992 Abstract
  8. World Health Organization (WHO) Task Force on Oral Contraceptives. Effects of hormonal contraceptives on breast milk composition and infant growth. Stud Fam Plann. 1988 Abstract
  9. Laukaran VH. The effects of contraceptive use on the initiation and duration of lactation. Int J Gynaecol Obstet. 1987 Abstract
  10. Betrabet SS, Shikary ZK, Toddywalla VS, Patel D, Vaidya P, Saxena BN. ICMR Task Force Study on hormonal contraception. Biological activity of ethinyl estradiol present in the breast milk. Contraception. 1986 Abstract
  11. Nilsson S, Mellbin T, Hofvander Y, Sundelin C, Valentin J, Nygren KG. Long-term follow-up of children breast-fed by mothers using oral contraceptives. Contraception. 1986 Abstract
  12. Madhavapeddi R, Ramachandran P. Side effects of oral contraceptive use in lactating women--enlargement of breast in a breast-fed child. Contraception. 1985 Abstract
  13. Tankeyoon M, Dusitsin N, Chalapati S, Koetsawang S, Saibiang S, Sas M, Gellen JJ, Ayeni O, Gray R, Pinol A, et al. Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives. Contraception. 1984 Abstract
  14. Díaz S, Peralta O, Juez G, Herreros C, Casado ME, Salvatierra AM, Miranda P, Durán E, Croxatto HB. Fertility regulation in nursing women: III. Short-term influence of a low-dose combined oral contraceptive upon lactation and infant growth. Contraception. 1983 Abstract
  15. Peralta O, Díaz S, Juez G, Herreros C, Casado ME, Salvatierra AM, Miranda P, Durán E, Croxatto HB. Fertility regulation in nursing women: V. Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum upon lactation and infant growth. Contraception. 1983 Abstract
  16. Nilsson S, Nygren KG, Johansson ED. Ethinyl estradiol in human milk and plasma after oral administration. Contraception. 1978 Abstract
  17. Nilsson S, Nygren KG, Johansson ED. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women. Am J Obstet Gynecol. 1977 Abstract
  18. Guiloff E, Ibarra-Polo A, Zañartu J, Toscanini C, Mischler TW, Gómez-Rogers C. Effect of contraception on lactation. Am J Obstet Gynecol. 1974 Abstract
  19. Balmer HC, Macdonald DJ. Hormonal therapy for suppressing lactation. Can Fam Physician. 1971 Abstract Full text (link to original source) Full text (in our servers)
  20. Kora SJ. Effect of oral contraceptives on lactation. Fertil Steril. 1969 Abstract
  21. Billingsley FS. Lactation suppression utilizing norethynodrel with mestranol. J Fla Med Assoc. 1969 Abstract
  22. Gillibrand PN, Huntingford PJ. Inhibition of lactation with combined oestrogen and progestogen. Br Med J. 1968 Abstract Full text (link to original source) Full text (in our servers)
  23. Laumas KR, Malkani PK, Bhatnagar S, Laumas V. Radioactivity in the breast milk of lactating women after oral administration of 3H-norethynodrel. Am J Obstet Gynecol. 1967 Abstract
  24. Pincus G, Bialy G, Layne DS, Paniagua M, Williams KI. Radioactivity in the milk of subjects receiving radioactive 19-norsteroids. Nature. 1966 Abstract
  25. CURTIS EM. ORAL-CONTRACEPTIVE FEMINIZATION OF A NORMAL MALE INFANT: REPORT OF A CASE. Obstet Gynecol. 1964 Abstract
  26. Lagrange M. [Inhibition of the establishment of milk flow with an orally active progestational norsteroid]. Gynecol Prat. 1964 Abstract

Total visits

8,240

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Instituto de Salud Infantil, Grecia-Institute of Child´s Health in Greece

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM